Evaluation of the importance of astrocytes when screening for acute toxicity in neuronal cell systems

Neurotoxicity Research

Volumn 17, Issue 2, 2010, Pages 103-113

  Woehrling, E K ^a   Hill, E J ^a   Coleman, M D ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Co culture; Human; In vitro; Neurons; NT2.A; NT2.N

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLORIDE; CHLOROQUINE; GLUTATHIONE; NEUROTOXIN; OXIDOPAMINE; TRIMETHYLTIN; BETA III TUBULIN PROTEIN, HUMAN; BETA III-TUBULIN PROTEIN, HUMAN; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GLIAL FIBRILLARY ACIDIC PROTEIN; OXAZINE DERIVATIVE; RESAZURIN; TUBULIN; XANTHENE DERIVATIVE;

ACUTE TOXICITY; ARTICLE; ASTROCYTE; CELL DISRUPTION; CELL FUNCTION; CELL SCREENING; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; EMBRYO; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; METABOLIC REGULATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOCULTURE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL NETWORK; NEUROCHEMISTRY; NEUROMODULATION; NEUROPROTECTION; PREDICTION; PRIORITY JOURNAL; PROTEIN DEPLETION; TOXICITY TESTING; ANALYSIS OF VARIANCE; CELL DIFFERENTIATION; CELL LINE; COCULTURE; DRUG EFFECT; DRUG SCREENING; METABOLISM; METHODOLOGY; NERVE CELL; PHYSIOLOGY; SPECTROPHOTOMETRY; TERATOCARCINOMA; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DRUG EVALUATION, PRECLINICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HUMANS; INDICATORS AND REAGENTS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEURONS; NEUROTOXINS; OXAZINES; SPECTROPHOTOMETRY; TERATOCARCINOMA; TUBULIN; XANTHENES;

EID: 77449103655     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-009-9084-3     Document Type: Article

References (67)

1. Almeida A, Almeida J, Bolanos JP, Moncada S (2001) Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci USA 98:15294-15299
2. Andrews PW (1984) Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell-Line in vitro. Dev Biol 103:285-293
3. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Fogh J (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell-line Tera-2-differentiation in vivo and in vitro. Lab Invest 50:147-162
4. Ba F, Pang PKT, Benishin CG (2003) The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J Neurosci Meth 123:11-22
5. Bal-Price AK, Sunol C, Weiss DG, van Vliet E, Westerink RHS, Costa LG (2008) Application of in vitro neurotoxicity testing for regulatory purposes: symposium III summary and research needs. Neurotoxicology 29:520-531
6. Bani-Yaghoub M, Felker JM, Naus CCG (1999) Human NT2/D1 cells differentiate into functional astrocytes. NeuroReport 10:3843-3846
7. Blaauboer BJ (2008) The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives. Toxicol Lett 180:81-84
8. Bruinink A, Zimmermann G, Riesen F (1991) Neurotoxic effects of chloroquine invitro. Arch Toxicol 65:480-484
9. Clemedson C, Kolman A, Forsby A (2007) The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests. ATLA-Altern Lab Anim 35:33-38
10. Coecke S, Eskes C, Gartlon J, Kinsner A, Price A, van Vliet E, Prieto P, Boveri M, Bremer S, Adler S (2006) The value of alternative testing for neurotoxicity in the context of regulatory needs. Environ Toxicol Pharmacol 21:153-167
11. Cookson MR, Mead C, Austwick SM, Pentreath VW (1995) Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell-cultures. Toxicol In Vitro 9:39-42
12. Costa LG (1998a) Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and risk assessment. Toxicol Lett 103:417-421
13. Costa LG (1998b) Neurotoxicity testing: a discussion of in vitro alternatives. Environ Health Persp 106:505-510
14. Cristofol RM, Gasso S, Vilchez D, Pertusa M, Rodriguez-Farre E, Sanfeliu C (2004) Neurotoxic effects of trimethyltin and triethyltin on human fetal neuron and astrocyte cultures: a comparative study with rat neuronal cultures and human cell lines. Toxicol Lett 152:35-46
15. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 64:9-671
16. Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain-metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912-4916
17. Eyer CL, Rio C, Smith JR (2000) Trimethyltin reduces ATP levels and MTT reduction in the LRM55 rat astrocytoma cell line. Vitro Mol Toxicol 13:263-268
18. Fiedorowicz A, Figiel L, Kaminska B, Zaremba M, Wilk S, Oderfeld-Nowak B (2001) Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res 912:116-127
19. Florea AM, Splettstoesser F, Dopp E, Rettenmeier AW, Busselberg D (2005) Modulation of intracellular calcium homeostasis by trimethyltin chloride in human tumour cells: neuroblastoma SY5Y and cervix adenocarcinoma HeLaS3. Toxicology 216:1-8
20. Forsby A, Blaauboer B (2007) Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Hum Exp Toxicol 26:333-338
21. Gabryel B, Adamek M, Pudelko A, Malecki A, Trzeciak HI (2002) Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology 23:19-31
22. Garcia de Arriba S, Wegner F, Gruener K, Verdaguer E, Pallas M, Camins A, Wagner A, Wohlfahrt K, Allgaier C (2006) Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons. Neurochem Int 49:466-474
23. Gartlon J, Kinsner A, Bal-Price A, Coecke S, Clothier RH (2006) Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol In Vitro 20:1569-1581
24. Gegg ME, Beltran B, Salas-Pino S, Bolanos JP, Clark JB, Moncada S, Heales SJ (2003) Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? J Neurochem 86:228-237
25. Guillemain I, Alonso G, Patey G, Privat A, Chaudieu I (2000) Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro. J Comp Neurol 422:380-395
26. Harry GJ, Tiffany-Castiglioni E (2005) Evaluation of neurotoxic potential by use of in vitro systems. Expert Opin Drug Metab Toxicol 1:701-713
27. Harry GJ, Billingsley M, Bruinink A, Campbell IL, Classen W, Dorman DC, Galli C, Ray D, Smith RA, Tilson HA (1998) In vitro techniques for the assessment of neurotoxicity. Environ Health Persp 106:131-158
28. Hartley RS, Margulis M, Fishman PS, Lee VMY, Tang CM (1999) Functional synapses are formed between human NTera2 (NT2N, hNT) neurons grown on astrocytes. J Comp Neurol 407:1-10
29. Heijink E, Scholten SW, Bolhuis PA, de Wolff FA (2000) Effects of 2,5-hexanedione on calpain-mediated degradation of human neurofilaments in vitro. Chem-Biol Interact 129:231-247
30. Hill EJ, Woehrling EK, Prince M, Coleman MD (2008) Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing. Toxicology 249:243-250
31. Holden LJ, Coleman MD (2008) Further preliminary assessment of three human glioma cell lines as models of human astrocytic toxicity in vitro. Environ Toxicol Pharmacol 26:290-296
32. Iwasaki K, Tsuruta H (1984) Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione. Ind Health 22:177-187
33. Kaariainen TM, Piltonen M, Ossola B, Kekki H, Lehtonen S, Nenonen T, Lecklin A, Raasmaja A, Mannisto PT (2008) Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Res 1203:149-159
34. Karpiak VC, Eyer CL (1999) Differential gliotoxicity of organotins. Cell Biol Toxicol 15:261-268
35. Larson EM, Doughman DJ, Gregerson DS, Obritsch WF (1997) A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest Ophth Vis Sci 38:1929-1933
36. Lim JH, Gibbons HM, O'Carroll SJ, Narayan PJ, Faull RLM, Dragunow M (2007) Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Res 1164:1-13
37. Lopachin RM, Aschner M (1993) Glial neuronal interactions- relevance to neurotoxic mechanisms. Toxicol Appl Pharmacol 118:141-158
38. Marini AM, Nowak TS (2000) Metabolic effects of 1-methyl-4- phenylpyridinium (MPP?) in primary neuron cultures. J Neurosci Res 62:814-820
39. Massicotte C, Knight K, Van Der Schyf CJ, Jortner BS, Ehrich M (2005) Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells. Neurotox Res 7:203-217
40. Nicholls DG, Budd SL (2000) Mitochondria and neuronal survival. Physiol Rev 80:315-360
41. Nicholls DG, Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23:166-174
42. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267:5421-5426
43. O'Callaghan JP (1991) Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci 4:197-206
44. O'Callaghan JP, Jensen KF, Miller DB (1995) Quantitative aspects of drug and toxicant-induced astrogliosis. Neurochem Int 26:115-124
45. Page B, Page M, Noel C (1993) A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 3:473-476
46. Paquet-Durand F, Bicker G (2007) Human model neurons in studies of brain cell damage and neural repair. Curr Mol Med 7:541-554
47. Paquet-Durand F, Gierse A, Bicker G (2006) Diltiazem protects human NT-2 neurons against excitotoxic damage in a model of simulated ischemia. Brain Res 1124:45-54
48. Park JS, Choi KS, Jeong EJ, Kwon DH, Benveniste EN, Choi CH (2004) Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 47:9-20
49. Pellerin L, Magistretti PJ (2003) How to balance the brain energy budget while spending glucose differently. J Physiol-London 546:325
50. Pleasure SJ, Page C, Lee VMY (1992) Pure, postmitotic, polarized human neurons derived from Ntera-2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 2:1802-1815
51. Radio NM, Mundy WR (2008) Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29:361-376
52. Sandhu JK, Sikorska M, Walker PR (2002) Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J Neurosci Res 68:604-614
53. Schuliga M, Chouchane S, Snow ET (2002) Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol Sci 70:183-192
54. Sergent-Tanguy S, Chagneau C, Neveu I, Naveilhan P (2003) Fluorescent activated cell sorting (FACS): a rapid and reliable method to estimate the number of neurons in a mixed population. J Neurosci Meth 129:73-79
55. Seyfried TN, Mukherjee P (2005) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab 2:30-39
56. Slaughter MR, Bugelski PJ, O'Brien PJ (1999) Evaluation of Alamar Blue reduction for the in vitro assay of hepatocyte toxicity. Toxicol In Vitro 13:567-569
57. Stewart R, Christie VB, Przyborski SA (2003) Manipulation of human pluripotent embryonal carcinoma stem cells and the development of neural subtypes. Stem Cells 21:248-256
58. Takuma K, Baba A, Matsuda T (2004) Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111-127
59. Tieu K, Ashe PC, Zuo DM, Yu PH (2001) Inhibition of 6-hydroxydopamine- induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes. Neuroscience 103:125-132
60. Van Houten B, Woshner V, Santos JH (2006) Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair 5:145-152
61. Veronesi B (1992) Invitro screening batteries for neurotoxicants. Neurotoxicology 13:185-195
62. Watts LT, Rathinam ML, Schenker S, Henderson GI (2005) Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death. J Neurosci Res 80:655-666
63. Woehrling EK, Hill EJ, Coleman MD (2007) Development of a neurotoxicity test-system, using human post-mitotic, astrocytic and neuronal cell lines in co-culture. Toxicol In Vitro 21:1241-1246
64. Wullner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Loschmann PA, Schulz JB, Weller M, Klockgether T (1999) Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res 826:53-62
65. Xu LJ, Lee JE, Giffard RG (1999) Overexpression of bcl-2, bcl-x(L) or hsp70 in murine cortical astrocytes reduces injury of cocultured neurons. Neurosci Lett 19:3-197
66. Yu PH, Zuo DM (1997) Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes. Neuroscience 78:903-912
67. Zhang FL, Xu ZF, Gao J, Xu B, Deng Y (2008) In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol 26:232-236